Skip to content

Hisamitsu Pharmaceutical

Hisamitsu Pharmaceutical Co. is a Japanese pharmaceutical company known for topical analgesics and its Salonpas franchise.

Last updated October 14, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Hisamitsu Pharmaceutical is a Japanese pharmaceutical company with roots dating to 1847 and headquarters in Tosu, Saga Prefecture. The company is principally associated with topical medicines, particularly patches and related external-use products intended to deliver analgesic and anti-inflammatory treatment. Its Salonpas franchise is the best-known expression of the brand and has given Hisamitsu recognition beyond Japan. The company's business identity is built around the Japanese idea of treatment through direct care, expressed in its corporate mission as bringing the culture of "teate"—care or hands-on treatment—to people around the world. This positioning connects product development with practical, easy-to-use healthcare formats, especially products applied to the skin. In addition to pain-relief and anti-inflammatory patches, the company's product categories include other topical treatments and cooling or fever-related products, although the exact assortment varies by market and regulatory authorization. Hisamitsu operates in Japan and international markets. Its global visibility is primarily linked to Salonpas, a brand used for topical relief of muscle and joint discomfort. The franchise has helped establish the company as a recognizable Japanese healthcare name in overseas markets while its domestic business remains rooted in pharmaceutical and consumer healthcare products. The company is publicly listed in Japan under ticker 4500.T. Historically, Hisamitsu developed from a long-established Japanese medicinal business into a modern pharmaceutical company focused on external preparations and drug-delivery technology. Its corporate communications emphasize improving quality of life and providing products and services characterized by consideration for users. Based on the available reference material, the company remains active, internationally oriented, and strongly identified with topical analgesic products rather than with a single prescription-drug category.

History

Hisamitsu Pharmaceutical traces its origins to 1847 in Japan. The available material does not identify the original founder or provide a detailed chronology of the company's early operations, but the long history places the business among Japan's established pharmaceutical enterprises. Over time, Hisamitsu developed a distinctive specialization in medicines applied externally to the body, particularly products designed to relieve pain and inflammation through patches and other topical formats. This focus became central to the company's identity. Rather than relying solely on conventional oral dosage forms, Hisamitsu built expertise around the formulation, manufacture, and commercialization of external preparations. Such products are intended to be practical for everyday use and to provide localized treatment for muscle, joint, and related discomfort. The approach also supports a clear consumer proposition: treatment that is simple to apply and integrated into daily life. Salonpas became the company's leading international brand. Its association with topical pain relief helped carry the Hisamitsu name into markets outside Japan and made the company particularly recognizable in consumer healthcare. The exact dates and sequence of Salonpas product launches in individual markets are not established by the supplied sources, so those details are not stated here. In its modern corporate presentation, Hisamitsu frames its purpose around improving quality of life for people worldwide. It describes its mission through the idea of bringing Japan's culture of "teate," or caring treatment, to the world. This language reflects a business model combining pharmaceutical expertise with an emphasis on user consideration, accessibility, and practical healthcare services. The company is headquartered in Tosu, Saga Prefecture, and is publicly traded in Japan under ticker 4500.T. Its activities include domestic Japanese operations and international business, with the strongest available evidence of global reach coming from the Salonpas franchise. The supplied material does not provide sufficiently reliable information about current executives, subsidiaries, acquisition history, financial performance, or a detailed year-by-year corporate chronology. Hisamitsu is nevertheless identifiable as an active Japanese pharmaceutical company whose primary brand association is topical analgesic and anti-inflammatory treatment.

  • 1847

    Business founded

    [1]

    Hisamitsu Pharmaceutical traces its origins to 1847 in Japan, establishing the historical foundation of the company.

Products and positioning

A pharmaceutical and consumer-healthcare company centered on convenient topical treatment, pain relief, anti-inflammatory care, and quality-of-life improvement.

  • Topical analgesics

    Salonpas

    Salonpas is Hisamitsu's best-known product franchise and the principal source of its international consumer recognition. It is associated with topical relief for muscle and joint pain and is offered in patch and other external-use formats depending on the market. Product composition, indications, labeling, and availability can differ by country because they are governed by local regulatory requirements.

  • External-use pharmaceuticals

    Topical anti-inflammatory patches

    Hisamitsu's topical anti-inflammatory patch category represents the company's core pharmaceutical specialization. These products are designed to deliver active ingredients through external application for localized relief of pain and inflammation. Individual formulations and brand names vary by market, and the supplied material does not establish a complete current product list.

  • Consumer healthcare

    Cooling and fever-relief products

    The company's broader external-use portfolio includes cooling or fever-relief products. These products extend Hisamitsu's healthcare positioning beyond analgesic patches, although specific current brands, launch dates, and market availability are not documented in the supplied reference material.

Sources1 sources

Cite this profile: Cite the canonical profile. /brand-wiki/久光製薬 · Editorial policy · How profiles are compiled